Niagen

AssetAlso nicotinamide riboside, NiagenPlus, Nicotinamide Riboside and Pterostilbene, Niagen 100mg

Nicotinamide riboside acts as an NAD+ precursor to increase NAD+ levels.

Stage: Phase 1
Modality: Supplement
Target: Sirtuin signalling; 11
Indications: 55
Trials: 4
Developers

Indications

11

Fatigue
Phase 1, Recruiting, NCT07251608, clinicaltrials.gov, 10 Oct 2026
Pharmacokinetic
Phase 1, Completed, NCT02191462, clinicaltrials.gov, 8 Oct 2026
Recovery of function
Phase 1, Unknown, NCT03635411, clinicaltrials.gov, 10 Oct 2026

8 more

In the full profile

Targets and what it contains4
Owner and partners4
Trials55
Evidence for its targets4
Competitors12
Aging relevance3
Signals5

Every asset’s record: target, stage, trials and the evidence behind it.

Updated 10 Oct 2026, 10 sources